Retatrutide
Triple-agonist peptide for metabolic research
$95.00
Volume pricing
Free shipping over $85 · 42 vials in stock
Retatrutide — Triple-agonist peptide for metabolic research. Supplied as lyophilised powder with a batch-specific Certificate of Analysis, third-party verified by HPLC-UV/VIS and mass spectrometry.
Retatrutide acetate (GIP/GLP-1/glucagon triple agonist, 40 amino acids), mannitol and sodium phosphate buffer salts. No preservatives, no excipient fillers.
Reconstitute the 10 mg vial with 2 ml bacteriostatic water for a 5 mg/ml stock. Published metabolic research protocols work in the 0.15–1.5 mg per measurement point range. Draw with an insulin syringe, keep the reconstituted vial at 2–8 °C and discard after 30 days. For laboratory research only — not for human or veterinary use.
Store lyophilised at –20 °C protected from light. Once reconstituted with bacteriostatic water, keep at 2–8 °C and use within 30 days.
Dispatched within 24 hours, delivered in 3–5 working days across the Nordics with tracking. Discreet packaging and cold-chain handling. If a shipment is delayed, damaged or fails CoA verification we replace it.
Frequently bought together
Researchers often pair Retatrutide with these compounds.
Weight management
Semaglutide
GLP-1 receptor agonist for metabolic research
Purity: ≥99.50% · MW: 4113.58 Da
$85.00
View
Weight management
Tirzepatide
Dual agonist for metabolic research
Purity: ≥99.10% · MW: 4813.52 Da
$95.00
View
Weight management
Cagrilintide
Long-acting amylin analogue for metabolic research
Purity: ≥99.50% · MW: 3731.8 Da
$65.00
View
Lab equipment
Accuris Analytical Balance, 120 g
Electromagnetic sensor balance, 120 g capacity, 0.1 mg readability
Purity: 0.0001 g readability · MW: N/A
$6,020.00
View